No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3iirA, 0.6095, 3.96, 0.152, 190, 138, CRYSTAL STRUCTURE OF MIRACULIN LIKE PROTEIN FROM SEEDS OF MURRAYA KOENIGII
2, 3iirB, 0.6090, 3.98, 0.145, 190, 138, CRYSTAL STRUCTURE OF MIRACULIN LIKE PROTEIN FROM SEEDS OF MURRAYA KOENIGII
3, 3zc9A, 0.6011, 3.81, 0.156, 182, 135, CRYSTAL STRUCTURE OF MURRAYA KOENIGII MIRACULIN-LIKE PROTEIN AT 2.2 A RESOLUTION AT PH 4.6
4, 3zc8A, 0.6009, 3.81, 0.156, 182, 135, CRYSTAL STRUCTURE OF MURRAYA KOENIGII MIRACULIN-LIKE PROTEIN AT 2.2 A RESOLUTION AT PH 7.0
5, 1eylA, 0.5915, 3.80, 0.106, 179, 132, STRUCTURE OF A RECOMBINANT WINGED BEAN CHYMOTRYPSIN INHIBITOR
6, 3s8kA, 0.5914, 3.58, 0.133, 183, 128, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION
7, 4wbcA, 0.5913, 3.99, 0.104, 179, 134, 2.13 A STRUCTURE OF A KUNITZ-TYPE WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
8, 1fmzA, 0.5909, 3.82, 0.106, 179, 132, CRYSTAL STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN N14K.
9, 2dreC, 0.5908, 3.47, 0.117, 177, 128, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
10, 3s8jB, 0.5904, 3.63, 0.133, 181, 128, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 2.6A RESOLUTION
11, 5yczA, 0.5903, 3.52, 0.133, 178, 128, CRYSTAL STRUCTURE OF ALOCASIN; PROTEASE INHIBITOR FROM GIANT TARO (ARUM MACRORRHIZON) 
12, 2wbcA, 0.5903, 3.76, 0.115, 183, 130, REFINED CRYSTAL STRUCTURE (2.3 ANGSTROM) OF A WINGED BEAN CHYMOTRYPSIN INHIBITOR AND LOCATION OF ITS SECOND REACTIVE SITE
13, 4h9wA, 0.5896, 3.81, 0.098, 177, 132, CRYSTAL STRUCTURE OF A METHIONINE MUTANT OF WCI
14, 3bx1D, 0.5893, 3.31, 0.145, 181, 124, COMPLEX BETWEEN THE BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR AND THE SUBTILISIN SAVINASE
15, 3s8kB, 0.5889, 3.79, 0.132, 182, 129, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION
16, 3bx1C, 0.5888, 3.47, 0.144, 181, 125, COMPLEX BETWEEN THE BARLEY ALPHA-AMYLASE/SUBTILISIN INHIBITOR AND THE SUBTILISIN SAVINASE
17, 5yh4A, 0.5887, 3.76, 0.176, 179, 131, MIRACULIN-LIKE PROTEIN FROM VITIS VINIFERA 
18, 2dreD, 0.5883, 3.58, 0.117, 177, 128, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
19, 1fn0A, 0.5880, 3.83, 0.106, 177, 132, STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN N14D.
20, 2bebB, 0.5873, 3.73, 0.100, 173, 130, X-RAY STRUCTURE OF ASN TO THR MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR
21, 4tlpA, 0.5860, 3.80, 0.085, 175, 130, CRYSTAL STRUCTURE OF A ALANINE91 MUTANT OF WCI
22, 1wbcA, 0.5857, 3.95, 0.090, 183, 133, CRYSTALLIZATION AND PRELIMINARY X-RAY STUDIES OF PSOPHOCARPIN B1 A CHYMOTRYPSIN INHIBITOR FROM WINGED BEAN SEEDS
23, 2qyiD, 0.5851, 3.86, 0.092, 175, 130, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN
24, 2dreB, 0.5850, 3.29, 0.121, 173, 124, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
25, 3i29B, 0.5849, 3.77, 0.109, 175, 128, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN MUTANT TRYPSIN INHIBITOR WITH BOVINE TRYPSIN
26, 3qydB, 0.5845, 3.71, 0.108, 177, 130, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
27, 3qydC, 0.5843, 3.81, 0.107, 177, 131, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
28, 2et2A, 0.5835, 3.81, 0.092, 175, 130, CRYSTAL STRUCTURE OF AN ASN TO ALA MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
29, 1r8nA, 0.5832, 4.01, 0.121, 185, 132, THE CRYSTAL STRUCTURE OF THE KUNITZ (STI) TYPE INHIBITOR FROM SEEDS OF DELONIX REGIA
30, 1g9cA, 0.5826, 3.99, 0.036, 1287, 137, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4)
31, 3s8jA, 0.5821, 3.55, 0.135, 182, 126, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 2.6A RESOLUTION
32, 2qyiB, 0.5821, 3.90, 0.109, 175, 129, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN
33, 1s0dA, 0.5819, 4.08, 0.043, 1287, 138, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5
34, 2beaB, 0.5816, 3.60, 0.103, 170, 126, CRYSTAL STRUCTURE OF ASN14 TO GLY MUTANT OF WCI
35, 1s0cA, 0.5816, 4.01, 0.036, 1287, 137, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0
36, 1z0hB, 0.5813, 4.13, 0.043, 438, 138, N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B
37, 1s0eA, 0.5813, 4.02, 0.036, 1287, 137, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0
38, 1i1eA, 0.5813, 4.02, 0.036, 1287, 137, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN
39, 1g9bA, 0.5813, 4.02, 0.036, 1287, 137, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1)
40, 1epwA, 0.5808, 4.03, 0.036, 1287, 137, CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B
41, 1z0hA, 0.5807, 4.12, 0.051, 438, 138, N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B
42, 1g9dA, 0.5806, 4.04, 0.036, 1287, 137, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2)
43, 5yczB, 0.5804, 3.61, 0.119, 172, 126, CRYSTAL STRUCTURE OF ALOCASIN; PROTEASE INHIBITOR FROM GIANT TARO (ARUM MACRORRHIZON) 
44, 1s0bA, 0.5804, 4.04, 0.036, 1287, 137, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0
45, 3i2xA, 0.5801, 3.83, 0.085, 178, 130, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR HAVING REACTIVE SITE LOOP OF ETI ON THE SCAFFOLD OF WCI
46, 2beaA, 0.5800, 3.62, 0.094, 170, 127, CRYSTAL STRUCTURE OF ASN14 TO GLY MUTANT OF WCI
47, 1g9aA, 0.5800, 4.10, 0.043, 1287, 138, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3)
48, 5vidD, 0.5799, 4.12, 0.036, 420, 137, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
49, 3i2xB, 0.5799, 3.86, 0.098, 181, 132, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR HAVING REACTIVE SITE LOOP OF ETI ON THE SCAFFOLD OF WCI
50, 4ha2A, 0.5797, 3.84, 0.085, 174, 130, CRYSTAL STRUCTURE OFA PHENYL ALANINE 91 MUTANT OF WCI
51, 2esuA, 0.5783, 3.83, 0.085, 173, 130, CRYSTAL STRUCTURE OF ASN TO GLN MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
52, 2vxrA, 0.5780, 3.82, 0.061, 428, 132, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN
53, 3r4uA, 0.5777, 3.65, 0.078, 422, 129, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
54, 3r4uB, 0.5776, 3.64, 0.078, 422, 129, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
55, 3r4sA, 0.5771, 3.62, 0.093, 424, 129, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
56, 3r4sB, 0.5768, 3.63, 0.093, 424, 129, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
57, 3qydA, 0.5761, 3.87, 0.100, 177, 130, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
58, 4ha2B, 0.5758, 3.89, 0.085, 173, 129, CRYSTAL STRUCTURE OFA PHENYL ALANINE 91 MUTANT OF WCI
59, 3n7kB, 0.5758, 3.61, 0.094, 421, 128, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN
60, 5jlvB, 0.5757, 3.73, 0.047, 425, 129, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C
61, 3i2aB, 0.5757, 3.81, 0.093, 180, 129, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR PROTEIN STI(L)- WCI(S)
62, 5dssB, 0.5754, 3.70, 0.109, 185, 128, MP-4 CONTRIBUTES TO SNAKE VENOM NEUTRALIZATION BY MUCUNA PRURIENS SEEDS THROUGH STIMULATION OF CROSS-REACTIVE ANTIBODIES
63, 2np0A, 0.5750, 4.04, 0.037, 1289, 134, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN
64, 3veqA, 0.5745, 3.96, 0.100, 175, 130, A BINARY COMPLEX BETWWEN BOVINE PANCREATIC TRYPSIN AND A ENGINEERED MUTANT TRYPSIN INHIBITOR
65, 1avaC, 0.5742, 3.68, 0.153, 181, 124, AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED
66, 5jlvA, 0.5740, 3.72, 0.054, 425, 129, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C
67, 2nm1A, 0.5738, 3.93, 0.045, 430, 133, STRUCTURE OF BONT/B IN COMPLEX WITH ITS PROTEIN RECEPTOR
68, 3n7kA, 0.5736, 3.73, 0.101, 422, 129, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN
69, 5mk6A, 0.5735, 3.87, 0.053, 421, 131, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN A1 (CRYSTAL FORM 1)
70, 2bebA, 0.5730, 3.66, 0.111, 170, 126, X-RAY STRUCTURE OF ASN TO THR MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR
71, 5dvhA, 0.5729, 4.09, 0.127, 185, 134, STRUCTURE OF THE KUNITZ-TYPE CYSTEINE PROTEASE INHIBITOR PCPI-3 FROM POTATO
72, 2vuaA, 0.5727, 3.75, 0.054, 423, 129, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN
73, 6g5gB, 0.5725, 4.06, 0.045, 848, 134, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B MUTANT E1191M/S1199Y IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 2 
74, 6g5kA, 0.5724, 3.89, 0.038, 421, 132, CRYSTAL STRUCTURE OF THE BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE B IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 
75, 6g5fB, 0.5724, 3.98, 0.045, 845, 133, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B MUTANT E1191M/S1199Y IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 
76, 5vidB, 0.5724, 4.00, 0.045, 412, 133, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
77, 5vidC, 0.5722, 3.89, 0.045, 426, 132, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
78, 2vu9A, 0.5721, 3.74, 0.054, 425, 129, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B
79, 1avaD, 0.5720, 3.85, 0.152, 181, 125, AMY2/BASI PROTEIN-PROTEIN COMPLEX FROM BARLEY SEED
80, 1s0fA, 0.5715, 3.85, 0.045, 1276, 132, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0
81, 3e8lC, 0.5714, 3.68, 0.104, 176, 125, THE CRYSTAL STRUCTURE OF THE DOUBLE-HEADED ARROWHEAD PROTEASE INHIBITOR A IN COMPLEX WITH TWO TRYPSINS
82, 2iwtB, 0.5714, 3.63, 0.146, 181, 123, THIOREDOXIN H2 (HVTRXH2) IN A MIXED DISULFIDE COMPLEX WITH THE TARGET PROTEIN BASI
83, 6giwD, 0.5711, 3.29, 0.098, 163, 122, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-A 
84, 6gixD, 0.5710, 3.26, 0.116, 163, 121, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-B 
85, 6g5kB, 0.5710, 3.90, 0.038, 424, 132, CRYSTAL STRUCTURE OF THE BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE B IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 
86, 3n7lA, 0.5710, 3.58, 0.079, 418, 127, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D/C VPI 5993 BINDING DOMAIN
87, 4isqC, 0.5707, 3.50, 0.087, 414, 126, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
88, 3n7mA, 0.5707, 3.66, 0.062, 418, 128, CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995
89, 3azwB, 0.5707, 3.78, 0.062, 418, 129, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
90, 1s0gA, 0.5707, 3.97, 0.038, 1288, 133, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM
91, 3v0bA, 0.5706, 3.73, 0.047, 1280, 129, 3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
92, 3v0aA, 0.5706, 3.73, 0.047, 1280, 129, 2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
93, 4fvvB, 0.5704, 3.59, 0.079, 415, 127, CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C
94, 3azwA, 0.5703, 3.79, 0.070, 418, 129, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
95, 5tpcA, 0.5701, 3.77, 0.047, 425, 129, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE
96, 5lr0B, 0.5701, 3.60, 0.079, 412, 127, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT
97, 5vidA, 0.5700, 3.92, 0.045, 415, 132, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
98, 5vmrB, 0.5699, 3.82, 0.038, 419, 131, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.2110.4
99, 4isqA, 0.5698, 3.58, 0.071, 414, 127, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
100, 5lr0A, 0.5697, 3.68, 0.062, 407, 128, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT
101, 4kbbA, 0.5696, 3.91, 0.045, 417, 132, STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A
102, 4isqB, 0.5691, 3.59, 0.071, 413, 127, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
103, 4kbbB, 0.5687, 3.89, 0.046, 417, 131, STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A
104, 5hpzA, 0.5685, 3.42, 0.083, 175, 121, TYPE II WATER SOLUBLE CHL BINDING PROTEINS
105, 4isrB, 0.5685, 3.59, 0.063, 413, 127, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
106, 4fvvA, 0.5685, 3.58, 0.063, 412, 127, CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C
107, 4isrA, 0.5683, 3.58, 0.063, 414, 127, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
108, 4isrC, 0.5682, 3.59, 0.071, 413, 127, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
109, 5hpzB, 0.5681, 3.42, 0.083, 175, 121, TYPE II WATER SOLUBLE CHL BINDING PROTEINS
110, 3mppG, 0.5681, 3.71, 0.054, 403, 129, BOTULINUM NEUROTOXIN TYPE G RECEPTOR BINDING DOMAIN
111, 3i2aA, 0.5674, 3.99, 0.069, 180, 131, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR PROTEIN STI(L)- WCI(S)
112, 1xg6A, 0.5671, 3.93, 0.092, 179, 130, THE CRYSTAL STRUCTURE OF THE P1 MUTANT (LEU TO ARG)OF A WINGED BEAN CHYMOTRYPSIN INHIBITOR(KUNITZ)SOLVED AT 2.15A RESOLUTION
113, 1tieA, 0.5665, 3.47, 0.107, 166, 122, CRYSTAL STRUCTURE OF A KUNITZ-TYPE TRYPSIN INHIBITOR FROM ERYTHRINA CAFFRA SEEDS
114, 3obtA, 0.5660, 3.78, 0.047, 412, 128, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D LIGAND BINDING DOMAIN IN COMPLEX WITH N-ACETYLNEURAMINIC ACID
115, 2dreA, 0.5654, 3.34, 0.124, 172, 121, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
116, 5vmrA, 0.5653, 3.81, 0.046, 421, 130, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.2110.4
117, 6dr2D, 0.5643, 3.36, 0.057, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
118, 4an6A, 0.5642, 3.42, 0.132, 172, 121, KUNTIZ TYPE TRYPSIN INHIBITOR WITH FACTOR XA INHIBITORY ACTIVITY
119, 3rmxA, 0.5641, 3.97, 0.061, 404, 131, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
120, 3azvB, 0.5640, 3.56, 0.080, 405, 125, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
121, 5xozB, 0.5638, 3.69, 0.113, 179, 124, CRYSTAL STRUCTURE OF A KUNITZ TYPE TRYPSIN INHIBITOR FROM CICER ARIETINUML 
122, 3obrA, 0.5636, 3.93, 0.046, 418, 131, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN
123, 3azvA, 0.5628, 3.78, 0.071, 405, 127, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
124, 6es1A, 0.5627, 3.71, 0.039, 420, 128, CRYSTAL STRUCTURE OF THE BINDING DOMAIN FROM BOTULINUM NEUROTOXIN A2 BOUND TO EXTRACELLULAR DOMAIN OF HUMAN RECEPTOR SV2C 
125, 5moyA, 0.5626, 3.64, 0.040, 414, 125, CRYSTAL STRUCTURE OF THE BONT/A2 RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF ITS NEURONAL RECEPTOR SV2C
126, 6draD, 0.5625, 3.38, 0.057, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
127, 6draC, 0.5625, 3.38, 0.057, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
128, 6draB, 0.5625, 3.38, 0.057, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
129, 6draA, 0.5625, 3.38, 0.057, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
130, 5v38A, 0.5622, 3.66, 0.063, 418, 127, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE HA
131, 5fzyA, 0.5620, 3.72, 0.148, 185, 128, CRYSTAL STRUCTURE OF N19D POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP C2221 AND PH 3.5
132, 3rmyB, 0.5620, 3.98, 0.061, 398, 131, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
133, 3rmxB, 0.5615, 3.83, 0.047, 407, 129, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
134, 5jmcE, 0.5606, 3.75, 0.047, 419, 127, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
135, 5jmcA, 0.5604, 3.77, 0.039, 420, 127, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
136, 5l21A, 0.5598, 3.74, 0.055, 425, 127, CRYSTAL STRUCTURE OF BONT/A RECEPTOR BINDING DOMAIN IN COMPLEX WITH VHH C2
137, 5fzzA, 0.5598, 3.76, 0.142, 185, 127, CRYSTAL STRUCTURE OF POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P22121 AND PH 7.0
138, 6dr2C, 0.5596, 3.62, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
139, 6dr2B, 0.5596, 3.62, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
140, 6dr2A, 0.5596, 3.62, 0.080, 2191, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
141, 5xa1A, 0.5595, 3.58, 0.065, 1257, 124, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
142, 5fzuA, 0.5594, 3.63, 0.151, 185, 126, CRYSTAL STRUCTURE OF N19D POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P4322 AND PH 7.2
143, 5xozA, 0.5592, 3.63, 0.114, 178, 123, CRYSTAL STRUCTURE OF A KUNITZ TYPE TRYPSIN INHIBITOR FROM CICER ARIETINUML 
144, 5g00A, 0.5592, 3.63, 0.151, 185, 126, CRYSTAL STRUCTURE OF A POTATO STI-KUNITZ BIFUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P4322 AND PH 7.4
145, 6dqsC, 0.5591, 3.64, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
146, 3rmyC, 0.5591, 3.89, 0.046, 403, 130, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
147, 5xa1B, 0.5589, 3.60, 0.065, 1257, 124, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
148, 1avuA, 0.5589, 3.66, 0.089, 172, 123, TRYPSIN INHIBITOR FROM SOYBEAN (STI)
149, 5fnxA, 0.5588, 3.63, 0.159, 185, 126, CRYSTAL STRUCTURE AT PH 9.0 OF A POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P4322 AND PH 9.0
150, 6gixC, 0.5587, 3.17, 0.102, 161, 118, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-B 
151, 6dqjD, 0.5587, 3.63, 0.088, 2181, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
152, 6dqjC, 0.5587, 3.63, 0.088, 2181, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
153, 6dqjB, 0.5587, 3.63, 0.088, 2181, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
154, 6dqjA, 0.5587, 3.63, 0.088, 2181, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
155, 6nttA, 0.5586, 3.70, 0.097, 175, 124, X-RAY CRYSTAL STRUCTURE OF SOYBEAN TRYPSIN INHIBITOR (KUNITZ) COMPLEXED WITH 1;5-DISULFONYL NAPHTHALENE 
156, 3n7jA, 0.5583, 3.96, 0.046, 405, 130, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN
157, 3fuoA, 0.5582, 3.88, 0.054, 416, 129, THE CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A
158, 5fnwA, 0.5580, 3.66, 0.159, 185, 126, CRYSTAL STRUCTURE AT PH 7.0 OF A POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP P4322 AND PH 9.0
159, 5jmcG, 0.5577, 3.73, 0.040, 419, 126, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
160, 6dqnD, 0.5576, 3.64, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
161, 6dqnC, 0.5576, 3.64, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
162, 6dqnB, 0.5576, 3.64, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
163, 6dqnA, 0.5576, 3.64, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
164, 5fzyB, 0.5576, 3.85, 0.147, 185, 129, CRYSTAL STRUCTURE OF N19D POTATO STI-KUNITZ BI-FUNCTIONAL INHIBITOR OF SERINE AND ASPARTIC PROTEASES IN SPACE GROUP C2221 AND PH 3.5
165, 3uj4A, 0.5576, 3.72, 0.039, 486, 127, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
166, 6dqzC, 0.5573, 3.67, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
167, 6dqzB, 0.5572, 3.59, 0.089, 2188, 124, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
168, 1xzzA, 0.5570, 3.60, 0.056, 216, 124, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 1 INOSITOL 145-TRISPHOSPHATE RECEPTOR
169, 1avwB, 0.5570, 3.61, 0.090, 171, 122, COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR ORTHORHOMBIC CRYSTAL FORM
170, 6dqzA, 0.5568, 3.60, 0.089, 2188, 124, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
171, 5gugB, 0.5568, 3.59, 0.065, 1720, 124, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
172, 3oggA, 0.5566, 3.98, 0.046, 404, 130, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN D
173, 3rmxD, 0.5565, 3.92, 0.046, 406, 130, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
174, 2nyyA, 0.5561, 3.80, 0.039, 1267, 127, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
175, 6dr0C, 0.5560, 3.68, 0.080, 2193, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
176, 6dqzD, 0.5560, 3.67, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
177, 6dqvD, 0.5560, 3.67, 0.080, 2188, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
178, 6dqsA, 0.5560, 3.68, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
179, 2nz9A, 0.5560, 3.79, 0.047, 1267, 127, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
180, 6dqsD, 0.5559, 3.66, 0.072, 2192, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
181, 4ihzB, 0.5559, 3.75, 0.081, 163, 123, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
182, 4ihzA, 0.5559, 3.70, 0.081, 163, 123, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
183, 3uj0A, 0.5558, 3.73, 0.048, 502, 125, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
184, 3malB, 0.5558, 3.86, 0.055, 181, 127, CRYSTAL STRUCTURE OF THE SDF2-LIKE PROTEIN FROM ARABIDOPSIS THALIANA
185, 3rmxC, 0.5555, 3.94, 0.046, 403, 130, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
186, 5v38B, 0.5552, 3.72, 0.064, 416, 125, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE HA
187, 3malA, 0.5551, 3.93, 0.070, 181, 128, CRYSTAL STRUCTURE OF THE SDF2-LIKE PROTEIN FROM ARABIDOPSIS THALIANA
188, 6dqsB, 0.5546, 3.68, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
189, 3t8sB, 0.5544, 3.87, 0.070, 482, 128, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
190, 3ef2B, 0.5544, 3.84, 0.107, 291, 122, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
191, 5dzuA, 0.5543, 3.64, 0.129, 187, 124, STRUCTURE OF POTATO CATHEPSIN D INHIBITOR
192, 1ba7B, 0.5542, 3.61, 0.091, 169, 121, SOYBEAN TRYPSIN INHIBITOR
193, 5gugA, 0.5539, 3.63, 0.065, 1721, 124, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
194, 4jraA, 0.5539, 3.81, 0.047, 416, 127, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C
195, 3uj4B, 0.5536, 3.81, 0.047, 490, 128, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
196, 3rmyA, 0.5536, 3.98, 0.046, 401, 130, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
197, 4j2kB, 0.5534, 3.36, 0.118, 167, 119, CRYSTAL STRUCTURE OF A PLANT TRYPSIN INHIBITOR ECTI
198, 3t8sA, 0.5534, 3.85, 0.063, 501, 127, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
199, 4ii0A, 0.5531, 3.64, 0.082, 163, 122, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
200, 5jmcC, 0.5529, 3.81, 0.039, 417, 127, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
201, 3ef2D, 0.5529, 3.97, 0.113, 291, 124, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
202, 3uj0B, 0.5528, 3.72, 0.040, 502, 126, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
203, 3ef2C, 0.5528, 3.91, 0.097, 291, 124, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
204, 3ef2A, 0.5528, 3.97, 0.113, 291, 124, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
205, 5d61A, 0.5527, 3.97, 0.113, 292, 124, MOA-Z-VAD-FMK COMPLEX DIRECT ORIENTATION
206, 2ihoA, 0.5527, 3.88, 0.107, 292, 122, CRYSTAL STRUCTURE OF MOA A LECTIN FROM THE MUSHROOM MARASMIUS OREADES IN COMPLEX WITH THE TRISACCHARIDE GAL(13)GAL(14)GLCNAC
207, 5mu9A, 0.5526, 3.97, 0.113, 292, 124, MOA-E-64 COMPLEX
208, 5dzuB, 0.5526, 3.62, 0.138, 176, 123, STRUCTURE OF POTATO CATHEPSIN D INHIBITOR
209, 1avxB, 0.5526, 3.58, 0.083, 172, 120, COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR TETRAGONAL CRYSTAL FORM
210, 2nz9B, 0.5525, 3.82, 0.047, 1267, 127, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
211, 4ii0B, 0.5524, 3.69, 0.082, 163, 122, CRYSTAL STRUCTURE OF CRATABL A TRYPSIN INHIBITOR FROM CRATAEVA TAPIA
212, 3rmyD, 0.5523, 3.97, 0.046, 404, 130, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
213, 5d63A, 0.5521, 3.91, 0.097, 292, 124, MOA-Z-VAD-FMK INHIBITOR COMPLEX DIRECT/INVERTED DUAL ORIENTATION
214, 5d62A, 0.5516, 3.91, 0.097, 292, 124, MOA-Z-VAD-FMK COMPLEX INVERTED ORIENTATION
215, 4f83A, 0.5512, 3.94, 0.038, 413, 130, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN MOSAIC SEROTYPE C/D WITH A TETRAETHYLENE GLYCOL MOLECULE BOUND ON THE HCN SUB-DOMAIN AND A SULFATE ION AT THE PUTATIVE ACTIVE SITE
216, 3v0cA, 0.5511, 3.83, 0.062, 1277, 128, 4.3 ANGSTROM CRYSTAL STRUCTURE OF AN INACTIVE BONT/A (E224Q/R363A/Y366F)
217, 4iqpA, 0.5507, 3.90, 0.070, 419, 129, CRYSTAL STRUCTURE OF HCRA-W1266A
218, 5mk8A, 0.5503, 3.83, 0.056, 421, 126, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF THE FA HYBRID CLOSTRIDIUM BOTULINUM NEUROTOXIN
219, 4jraB, 0.5503, 3.98, 0.062, 413, 129, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C
220, 6giwC, 0.5501, 3.16, 0.103, 157, 116, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-A 
221, 5x9zA, 0.5500, 3.77, 0.071, 1710, 127, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
222, 5xa0A, 0.5499, 3.71, 0.063, 1252, 127, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
223, 4j2kA, 0.5499, 3.49, 0.107, 168, 121, CRYSTAL STRUCTURE OF A PLANT TRYPSIN INHIBITOR ECTI
224, 6dr0A, 0.5498, 3.67, 0.089, 2188, 124, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
225, 6gixB, 0.5496, 3.13, 0.122, 158, 115, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-B 
226, 6nttB, 0.5494, 3.77, 0.089, 176, 124, X-RAY CRYSTAL STRUCTURE OF SOYBEAN TRYPSIN INHIBITOR (KUNITZ) COMPLEXED WITH 1;5-DISULFONYL NAPHTHALENE 
227, 3pmeA, 0.5486, 4.03, 0.038, 415, 130, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN C/D MOSAIC SEROTYPE
228, 5xa0B, 0.5480, 3.71, 0.063, 1252, 126, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
229, 3btaA, 0.5479, 3.92, 0.054, 1277, 129, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A
230, 3tc2C, 0.5476, 3.84, 0.152, 178, 125, CRYSTAL STRUCTURE OF POTATO SERINE PROTEASE INHIBITOR.
231, 5mk8B, 0.5473, 3.85, 0.063, 420, 126, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF THE FA HYBRID CLOSTRIDIUM BOTULINUM NEUROTOXIN
232, 6f0pA, 0.5470, 3.96, 0.055, 418, 128, BOTULINUM NEUROTOXIN A4 HC DOMAIN
233, 6drcD, 0.5463, 3.75, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
234, 6drcC, 0.5463, 3.75, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
235, 6drcB, 0.5463, 3.75, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
236, 6drcA, 0.5463, 3.75, 0.080, 2186, 125, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
237, 1t9fA, 0.5460, 3.79, 0.049, 178, 123, STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION
238, 6dqvC, 0.5459, 3.96, 0.065, 2188, 124, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
239, 6dqvB, 0.5459, 3.96, 0.065, 2188, 124, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
240, 6dqvA, 0.5459, 3.96, 0.065, 2188, 124, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
241, 5x9zB, 0.5456, 3.72, 0.063, 1708, 126, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
242, 6giwA, 0.5450, 3.17, 0.104, 156, 115, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-A 
243, 3h6qA, 0.5444, 3.96, 0.114, 168, 123, MACROCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
244, 5mk7A, 0.5441, 3.88, 0.040, 397, 125, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN A1 (CRYSTAL FORM 2)
245, 1yynA, 0.5440, 4.35, 0.068, 441, 132, A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN
246, 6gixA, 0.5439, 3.18, 0.104, 157, 115, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-B 
247, 5tpbA, 0.5439, 3.76, 0.041, 411, 123, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE VARIANT
248, 1fv3B, 0.5439, 4.24, 0.077, 451, 130, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
249, 5tpbB, 0.5437, 3.81, 0.049, 407, 123, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE VARIANT
250, 6dr0B, 0.5434, 3.98, 0.065, 2188, 124, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
251, 1fv3A, 0.5434, 4.35, 0.068, 451, 132, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
252, 5n0cB, 0.5433, 4.22, 0.069, 1286, 130, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
253, 2qn4A, 0.5429, 3.30, 0.097, 159, 113, STRUCTURE AND FUNCTION STUDY OF RICE BIFUNCTIONAL ALPHA- AMYLASE/SUBTILISIN INHIBITOR FROM ORYZA SATIVA
254, 1af9A, 0.5429, 4.38, 0.068, 441, 132, TETANUS NEUROTOXIN C FRAGMENT
255, 3jrrA, 0.5424, 3.54, 0.075, 216, 120, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 3 INOSITOL 145-TRISPHOSPHATE RECEPTOR
256, 3tc2B, 0.5422, 3.79, 0.146, 177, 123, CRYSTAL STRUCTURE OF POTATO SERINE PROTEASE INHIBITOR.
257, 3tc2A, 0.5422, 3.87, 0.145, 181, 124, CRYSTAL STRUCTURE OF POTATO SERINE PROTEASE INHIBITOR.
258, 2qn4B, 0.5421, 3.18, 0.089, 159, 112, STRUCTURE AND FUNCTION STUDY OF RICE BIFUNCTIONAL ALPHA- AMYLASE/SUBTILISIN INHIBITOR FROM ORYZA SATIVA
259, 1fv2A, 0.5421, 4.36, 0.068, 451, 132, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
260, 1a8dA, 0.5421, 4.26, 0.076, 452, 131, TETANUS TOXIN C FRAGMENT
261, 3jrrB, 0.5415, 3.43, 0.059, 219, 119, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 3 INOSITOL 145-TRISPHOSPHATE RECEPTOR
262, 3rsjA, 0.5414, 3.73, 0.065, 406, 124, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
263, 5vidE, 0.5409, 3.76, 0.049, 405, 122, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
264, 5n0bA, 0.5406, 4.34, 0.069, 1280, 131, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GD1A
265, 1yxwA, 0.5405, 4.43, 0.068, 441, 132, A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN
266, 3rsjB, 0.5401, 3.52, 0.075, 402, 120, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
267, 5wvxA, 0.5397, 3.41, 0.103, 157, 116, CRYSTAL STRUCTURE OF BIFUNCTIONAL KUNITZ TYPE TRYPSIN /AMYLASE INHIBITOR (AMTIN) FROM THE TUBERS OF ALOCASIA MACRORRHIZA 
268, 1dfqA, 0.5395, 4.16, 0.062, 441, 128, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH SIALIC ACID
269, 5n0cA, 0.5394, 4.35, 0.069, 1293, 131, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
270, 3hmyA, 0.5391, 4.34, 0.069, 442, 131, CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2
271, 1dllA, 0.5387, 4.20, 0.078, 441, 129, THE HC FRAGEMENT OF TETANUS TOXIN COMPLEXED WITH LACTOSE
272, 6f0oA, 0.5382, 3.76, 0.041, 407, 123, BOTULINUM NEUROTOXIN A3 HC DOMAIN
273, 3hn1A, 0.5381, 4.35, 0.076, 442, 131, CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2 AND LACTOSE
274, 6dr0D, 0.5378, 4.09, 0.079, 2181, 127, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
275, 4uweD, 0.5369, 3.90, 0.131, 3322, 122, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
276, 4uweC, 0.5369, 3.90, 0.131, 3322, 122, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
277, 4uweB, 0.5369, 3.90, 0.131, 3322, 122, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
278, 4uweA, 0.5369, 3.90, 0.131, 3322, 122, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
279, 4uwaD, 0.5367, 3.90, 0.131, 3324, 122, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
280, 4uwaC, 0.5367, 3.90, 0.131, 3324, 122, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
281, 4uwaB, 0.5367, 3.90, 0.131, 3324, 122, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
282, 4uwaA, 0.5367, 3.90, 0.131, 3324, 122, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
283, 1diwA, 0.5366, 4.30, 0.077, 441, 130, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH GALACTOSE
284, 4hjjA, 0.5365, 3.45, 0.095, 157, 116, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
285, 2vxtI, 0.5364, 3.39, 0.096, 156, 115, CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
286, 1j0sA, 0.5364, 3.67, 0.110, 157, 118, SOLUTION STRUCTURE OF THE HUMAN INTERLEUKIN-18
287, 6mu2D, 0.5357, 3.85, 0.047, 2170, 127, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE 
288, 6mu2C, 0.5357, 3.85, 0.047, 2170, 127, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE 
289, 6mu2B, 0.5357, 3.85, 0.047, 2170, 127, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE 
290, 6mu2A, 0.5357, 3.85, 0.047, 2170, 127, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE 
291, 3rsjD, 0.5356, 3.59, 0.075, 404, 120, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
292, 6giwB, 0.5355, 3.17, 0.106, 155, 113, WATER-SOLUBLE CHLOROPHYLL PROTEIN (WSCP) FROM LEPIDIUM VIRGINICUM (MUTATION L91P) WITH CHLOROPHYLL-A 
293, 4an7B, 0.5350, 3.23, 0.124, 156, 113, KUNITZ TYPE TRYPSIN INHIBITOR COMPLEX WITH PORCINE TRYPSIN
294, 1d0hA, 0.5346, 4.40, 0.069, 441, 131, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH N-ACETYL- GALACTOSAMINE
295, 7i1bA, 0.5345, 3.38, 0.088, 153, 114, HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN- 1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
296, 3phzB, 0.5344, 3.46, 0.060, 278, 117, CRYSTAL STRUCTURE ANALYSIS OF POLYPORUS SQUAMOSUS LECTIN BOUND TO HUMAN-TYPE INFLUENZA-BINDING EPITOPE NEU5ACA2-6GALB1-4GLCNAC
297, 3ffzA, 0.5344, 3.72, 0.058, 1246, 120, DOMAIN ORGANIZATION IN CLOSTRIDIUM BUTULINUM NEUROTOXIN TYPE E IS UNIQUE: ITS IMPLICATION IN FASTER TRANSLOCATION
298, 3phzA, 0.5341, 3.47, 0.060, 278, 117, CRYSTAL STRUCTURE ANALYSIS OF POLYPORUS SQUAMOSUS LECTIN BOUND TO HUMAN-TYPE INFLUENZA-BINDING EPITOPE NEU5ACA2-6GALB1-4GLCNAC
299, 9ilbA, 0.5335, 3.52, 0.070, 153, 115, HUMAN INTERLEUKIN-1 BETA
300, 1s0lA, 0.5335, 3.44, 0.079, 153, 114, INTERLEUKIN 1 BETA MUTANT F42W
301, 5wvxB, 0.5333, 3.35, 0.088, 153, 113, CRYSTAL STRUCTURE OF BIFUNCTIONAL KUNITZ TYPE TRYPSIN /AMYLASE INHIBITOR (AMTIN) FROM THE TUBERS OF ALOCASIA MACRORRHIZA 
302, 2kh2A, 0.5332, 3.51, 0.078, 153, 115, SOLUTION STRUCTURE OF A SCFV-IL-1B COMPLEX
303, 3pokA, 0.5330, 3.59, 0.085, 159, 117, INTERLEUKIN-1-BETA LBT L3 MUTANT
304, 6mu1D, 0.5327, 4.17, 0.054, 2149, 130, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL BOUND WITH ADENOPHOSTIN A 
305, 6mu1C, 0.5327, 4.17, 0.054, 2149, 130, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL BOUND WITH ADENOPHOSTIN A 
306, 6mu1B, 0.5327, 4.17, 0.054, 2149, 130, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL BOUND WITH ADENOPHOSTIN A 
307, 6mu1A, 0.5327, 4.17, 0.054, 2149, 130, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL BOUND WITH ADENOPHOSTIN A 
308, 1twmA, 0.5327, 3.53, 0.070, 153, 115, INTERLEUKIN-1 BETA MUTANT F146Y
309, 1tweA, 0.5325, 3.53, 0.061, 153, 115, INTERLEUKIN 1 BETA MUTANT F101Y
310, 1i1bA, 0.5325, 3.51, 0.078, 151, 115, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION
311, 2i1bA, 0.5323, 3.53, 0.070, 153, 115, CRYSTALLOGRAPHIC REFINEMENT OF INTERLEUKIN-1 BETA AT 2.0 ANGSTROMS RESOLUTION
312, 1tp0A, 0.5323, 3.51, 0.070, 153, 115, TRIPLE MUTATION IN INTERLEUKIN 1 BETA CAVITY:REPLACEMENT OF PHENYLALANINES WITH TRYPTOPHAN.
313, 1t4qA, 0.5323, 3.53, 0.061, 153, 115, INTERLEUKIN 1 BETA F101W
314, 1tooA, 0.5319, 3.53, 0.070, 153, 115, INTERLEUKIN 1B MUTANT F146W
315, 4i1bA, 0.5318, 3.44, 0.096, 151, 114, FUNCTIONAL IMPLICATIONS OF INTERLEUKIN-1BETA BASED ON THE THREE-DIMENSIONAL STRUCTURE
316, 21biA, 0.5314, 3.51, 0.078, 151, 115, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY ALA) (C71A)
317, 1itbA, 0.5313, 3.58, 0.086, 153, 116, TYPE-1 INTERLEUKIN-1 RECEPTOR COMPLEXED WITH INTERLEUKIN-1 BETA
318, 6i1bA, 0.5310, 3.43, 0.088, 153, 114, HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN- 1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
319, 3wo2C, 0.5310, 3.54, 0.104, 157, 115, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
320, 2e4mA, 0.5307, 3.31, 0.070, 285, 114, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
321, 3wo2D, 0.5306, 3.56, 0.103, 157, 116, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
322, 5goaD, 0.5302, 4.10, 0.081, 3423, 124, 
323, 5goaA, 0.5301, 4.10, 0.081, 3423, 124, 
324, 5goaC, 0.5299, 4.10, 0.081, 3423, 124, 
325, 5goaB, 0.5299, 4.10, 0.081, 3423, 124, 
326, 1wbaA, 0.5299, 4.02, 0.089, 171, 123, WINGED BEAN ALBUMIN 1
327, 3aj5A, 0.5298, 3.34, 0.070, 283, 114, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
328, 3ah4A, 0.5298, 3.34, 0.070, 283, 114, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
329, 2xoaA, 0.5297, 4.09, 0.132, 461, 121, CRYSTAL STRUCTURE OF THE N-TERMINAL THREE DOMAINS OF THE SKELETAL MUSCLE RYANODINE RECEPTOR (RYR1)
330, 1iobA, 0.5297, 3.52, 0.096, 153, 115, INTERLEUKIN-1 BETA FROM JOINT X-RAY AND NMR REFINEMENT
331, 1qxmA, 0.5296, 3.33, 0.070, 283, 114, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
332, 5gl0E, 0.5292, 3.95, 0.148, 3660, 122, 
333, 5gl0C, 0.5292, 3.95, 0.148, 3660, 122, 
334, 3ah2A, 0.5292, 3.35, 0.070, 283, 114, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
335, 5gl0G, 0.5291, 3.95, 0.148, 3660, 122, 
336, 5gl0A, 0.5291, 3.95, 0.148, 3660, 122, 
337, 3wo4A, 0.5291, 3.59, 0.096, 157, 114, CRYSTAL STRUCTURE OF THE IL-18 SIGNALING TERNARY COMPLEX
338, 3aj6A, 0.5291, 3.34, 0.070, 283, 114, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
339, 4xfsB, 0.5289, 3.62, 0.078, 157, 115, STRUCTURE OF IL-18 SER MUTANT I
340, 3fuqA, 0.5288, 3.54, 0.085, 399, 117, GLYCOSYLATED SV2 AND GANGLIOSIDES AS DUAL RECEPTORS FOR BOTULINUM NEUROTOXIN SEROTYPE F
341, 2e4mB, 0.5286, 3.33, 0.070, 285, 114, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
342, 5go9D, 0.5285, 4.13, 0.081, 3423, 123, 
343, 5go9C, 0.5285, 4.13, 0.081, 3423, 123, 
344, 5go9B, 0.5285, 4.13, 0.081, 3423, 123, 
345, 5go9A, 0.5285, 4.13, 0.081, 3423, 123, 
346, 4l4iA, 0.5284, 4.02, 0.065, 473, 123, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR ISOFORM 2 (RYR2) 1-547 DISEASE MUTANT R420Q
347, 3aj5B, 0.5283, 3.35, 0.070, 283, 114, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
348, 5gkzE, 0.5282, 3.94, 0.133, 3660, 120, 
349, 3wo3E, 0.5282, 3.59, 0.095, 157, 116, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
350, 3ah2B, 0.5282, 3.37, 0.070, 283, 114, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
351, 5b2hB, 0.5280, 3.35, 0.070, 283, 114, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
352, 3wo2B, 0.5279, 3.52, 0.105, 156, 114, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
353, 3ah4B, 0.5279, 3.36, 0.070, 285, 114, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
354, 4g6jA, 0.5277, 3.55, 0.070, 149, 114, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB
355, 5gkyC, 0.5276, 3.96, 0.132, 3660, 121, 
356, 1qxmB, 0.5276, 3.35, 0.070, 283, 114, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
357, 6dwuD, 0.5275, 3.88, 0.120, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
358, 5gkyG, 0.5275, 3.87, 0.121, 163, 116, 
359, 5gkyE, 0.5275, 3.84, 0.121, 163, 116, 
360, 5gkyA, 0.5275, 3.71, 0.122, 163, 115, 
361, 3wo2A, 0.5272, 3.96, 0.132, 3660, 121, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-18
362, 3ah1B, 0.5272, 3.96, 0.132, 3660, 121, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
363, 2nvhA, 0.5272, 3.96, 0.132, 3660, 121, DETERMINATION OF SOLVENT CONTENT IN CAVITIES IN INTERLEUKIN- 1 USING EXPERIMENTALLY-PHASED ELECTRON DENSITY
364, 4xfsA, 0.5271, 3.61, 0.103, 157, 116, STRUCTURE OF IL-18 SER MUTANT I
365, 3aj6B, 0.5270, 3.38, 0.070, 288, 114, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
366, 3winA, 0.5268, 3.53, 0.070, 152, 114, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
367, 5b2hA, 0.5266, 3.58, 0.088, 156, 114, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
368, 6dwuJA, 0.5263, 3.37, 0.070, 284, 114, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
369, 6dwuV, 0.5262, 3.75, 0.068, 286, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
370, 5gkzA, 0.5261, 3.37, 0.070, 283, 114, 
371, 5bowA, 0.5261, 3.94, 0.120, 163, 117, CRYSTAL STRUCTURE OF IL-38
372, 5gkzG, 0.5260, 3.82, 0.121, 163, 116, 
373, 5fozB, 0.5259, 3.99, 0.119, 163, 118, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 10
374, 3o4oA, 0.5259, 3.72, 0.122, 163, 115, CRYSTAL STRUCTURE OF AN INTERLEUKIN-1 RECEPTOR COMPLEX
375, 3ah1A, 0.5256, 3.83, 0.134, 3660, 119, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
376, 5foyB, 0.5255, 3.90, 0.120, 151, 117, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 7
377, 4i6iA, 0.5254, 3.83, 0.134, 3660, 119, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-559) DISEASE MUTANT R45C
378, 6dwuNA, 0.5253, 3.68, 0.059, 419, 118, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
379, 6dwuJ, 0.5253, 3.53, 0.070, 152, 114, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
380, 5gkzC, 0.5251, 3.41, 0.070, 283, 114, 
381, 4pc4D, 0.5251, 3.70, 0.059, 421, 118, BOMBYX MORI LIPOPROTEIN 6
382, 41biA, 0.5251, 3.95, 0.150, 451, 120, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 8 REPLACED BY ALA (C8A)
383, 6dwuFA, 0.5250, 3.94, 0.120, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
384, 6dwuZB, 0.5249, 3.96, 0.111, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
385, 6dwuT, 0.5249, 3.94, 0.120, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
386, 4pc4A, 0.5248, 3.60, 0.115, 163, 113, BOMBYX MORI LIPOPROTEIN 6
387, 6dwuN, 0.5247, 3.79, 0.122, 163, 115, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
388, 2gzbA, 0.5247, 3.96, 0.124, 3660, 121, BAUHINIA BAUHINIOIDES CRUZIPAIN INHIBITOR (BBCI)
389, 5mvzV, 0.5245, 3.70, 0.103, 238, 117, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
390, 3wo3I, 0.5245, 3.51, 0.079, 150, 114, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
391, 6dwuL, 0.5244, 3.93, 0.120, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
392, 6dwuXA, 0.5243, 3.92, 0.120, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
393, 4pc4E, 0.5243, 3.89, 0.120, 163, 117, BOMBYX MORI LIPOPROTEIN 6
394, 6dwuLB, 0.5241, 3.83, 0.121, 163, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
395, 6dwuRB, 0.5240, 3.69, 0.123, 163, 114, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
396, 4pc4C, 0.5240, 3.62, 0.103, 238, 116, BOMBYX MORI LIPOPROTEIN 6
397, 3nbeA, 0.5239, 3.95, 0.128, 163, 117, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH NN - DIACETYLLACTOSEDIAMINE
398, 5i1bA, 0.5238, 3.94, 0.120, 163, 117, A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B
399, 4pc4B, 0.5238, 3.68, 0.123, 163, 114, BOMBYX MORI LIPOPROTEIN 6
400, 4ekxD, 0.5238, 3.89, 0.118, 164, 119, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
401, 5g37B, 0.5237, 3.60, 0.080, 144, 113, MR STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 5
402, 4oujB, 0.5237, 3.56, 0.096, 156, 114, CRYSTAL STRUCTURE OF HA33B-LAC
403, 6dwuLA, 0.5236, 3.91, 0.120, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
404, 3wo3C, 0.5236, 3.71, 0.122, 163, 115, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
405, 6dwuF, 0.5235, 3.92, 0.120, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
406, 6dwuXB, 0.5234, 3.95, 0.128, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
407, 6dwuRA, 0.5233, 3.72, 0.103, 239, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
408, 4gafA, 0.5233, 3.92, 0.120, 163, 117, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA BOUND TO HUMAN INTERLEUKIN-1 RECEPTOR TYPE 1
409, 6dwuH, 0.5232, 3.72, 0.122, 163, 115, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
410, 4gaiA, 0.5232, 3.72, 0.103, 240, 117, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA
411, 6dwuFC, 0.5231, 3.21, 0.090, 147, 111, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
412, 6dwuTA, 0.5230, 3.84, 0.067, 151, 119, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
413, 6dwuDC, 0.5230, 3.63, 0.103, 238, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
414, 3wo3K, 0.5230, 3.62, 0.096, 155, 114, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
415, 3nbeB, 0.5230, 3.80, 0.059, 420, 119, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH NN - DIACETYLLACTOSEDIAMINE
416, 2gzbB, 0.5230, 3.76, 0.077, 281, 117, BAUHINIA BAUHINIOIDES CRUZIPAIN INHIBITOR (BBCI)
417, 6dwuBA, 0.5229, 3.71, 0.122, 163, 115, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
418, 6dwuX, 0.5227, 3.52, 0.097, 156, 113, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
419, 3wa1A, 0.5227, 3.98, 0.111, 163, 117, CRYSTAL STRUCTURE OF BINB: A RECEPTOR BINDING COMPONENT OF THE BINARY TOXIN FROM LYSINIBACILLUS SPHAERICUS
420, 3ltqA, 0.5227, 3.93, 0.120, 163, 117, STRUCTURE OF INTERLEUKIN 1B SOLVED BY SAD USING AN INSERTED LANTHANIDE BINDING TAG
421, 6dwuHC, 0.5226, 3.90, 0.121, 163, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
422, 6dwuFB, 0.5226, 3.84, 0.121, 163, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
423, 4l4hA, 0.5226, 3.84, 0.121, 163, 116, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR ISOFORM 2 (RYR2) 1-547
424, 6dwuVB, 0.5225, 3.83, 0.121, 163, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
425, 6dwuDB, 0.5225, 3.63, 0.034, 152, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
426, 6dwuBC, 0.5225, 3.84, 0.121, 163, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
427, 6dwuP, 0.5224, 3.74, 0.122, 163, 115, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
428, 4r6uD, 0.5224, 3.80, 0.122, 163, 115, IL-18 RECEPTOR COMPLEX
429, 6dwuZ, 0.5223, 3.91, 0.128, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
430, 6dwhL, 0.5223, 3.70, 0.034, 152, 117, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
431, 6dwuZA, 0.5222, 3.84, 0.121, 163, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
432, 3wo3A, 0.5222, 3.83, 0.121, 163, 116, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
433, 6dwuPA, 0.5220, 3.71, 0.122, 163, 115, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
434, 4i1eA, 0.5220, 3.59, 0.096, 156, 114, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT G249R
435, 6dwhJ, 0.5219, 3.19, 0.100, 147, 110, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
436, 4oujA, 0.5218, 3.91, 0.109, 163, 119, CRYSTAL STRUCTURE OF HA33B-LAC
437, 6dwuBB, 0.5217, 3.74, 0.122, 163, 115, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
438, 6dwfJ, 0.5214, 3.73, 0.122, 163, 115, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
439, 4lo1A, 0.5214, 3.95, 0.128, 163, 117, HA17-HA33-GAL
440, 6dwfL, 0.5213, 3.84, 0.121, 163, 116, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
441, 6dwuHA, 0.5212, 3.82, 0.059, 389, 118, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
442, 3wo3G, 0.5212, 3.56, 0.070, 168, 114, CRYSTAL STRUCTURE OF IL-18 IN COMPLEX WITH IL-18 RECEPTOR ALPHA
443, 6dwuJC, 0.5211, 3.91, 0.128, 163, 117, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
444, 3javC, 0.5210, 3.90, 0.121, 163, 116, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
445, 3javA, 0.5210, 3.97, 0.066, 466, 121, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
446, 6dwhH, 0.5209, 3.72, 0.122, 163, 115, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
447, 4lo7F, 0.5209, 3.84, 0.121, 163, 116, HA70(D3)-HA17-HA33
448, 4lo7B, 0.5209, 3.77, 0.122, 163, 115, HA70(D3)-HA17-HA33
449, 4lo0A, 0.5209, 3.75, 0.122, 163, 115, APO HA17-HA33
450, 6dwuDA, 0.5207, 3.87, 0.121, 163, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
451, 5bquA, 0.5207, 3.71, 0.123, 163, 114, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
452, 4lo2A, 0.5207, 3.54, 0.097, 155, 113, HA17-HA33-LAC
453, 4lo1B, 0.5207, 3.86, 0.121, 163, 116, HA17-HA33-GAL
454, 4g6mA, 0.5207, 3.75, 0.122, 163, 115, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
455, 3nbdB, 0.5207, 3.92, 0.120, 163, 117, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 7.1
456, 2mibA, 0.5207, 3.87, 0.121, 163, 116, THE STRUCTURE OF MURINE INTERLEUKIN-1 BETA AT 2.8 ANGSTROMS RESOLUTION
457, 6dwfI, 0.5206, 3.75, 0.122, 163, 115, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
458, 4lo3A, 0.5206, 3.59, 0.106, 156, 113, HA17-HA33-LACNAC
459, 4iy8B, 0.5206, 3.87, 0.121, 163, 116, BMLP3 - P21 CRYSTAL FORM
460, 3javD, 0.5206, 3.97, 0.153, 484, 118, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
461, 3javB, 0.5206, 3.88, 0.121, 163, 116, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
462, 2go2A, 0.5206, 3.82, 0.077, 281, 117, CRYSTAL STRUCTURE OF BBKI A KUNITZ-TYPE KALLIKREIN INHIBITOR
463, 4lo7H, 0.5205, 3.77, 0.122, 163, 115, HA70(D3)-HA17-HA33
464, 4lo7D, 0.5205, 3.88, 0.121, 163, 116, HA70(D3)-HA17-HA33
465, 4lo0B, 0.5205, 3.67, 0.112, 286, 116, APO HA17-HA33
466, 6dwhK, 0.5203, 3.89, 0.121, 163, 116, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
467, 6dwuB, 0.5202, 3.74, 0.122, 163, 115, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
468, 5gl1G, 0.5202, 3.62, 0.096, 156, 115, 
469, 5gl1A, 0.5202, 3.79, 0.122, 163, 115, 
470, 6dwuNB, 0.5201, 3.95, 0.073, 2327, 123, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
471, 5gl1E, 0.5201, 3.95, 0.073, 2327, 123, 
472, 5gl1C, 0.5201, 3.88, 0.121, 163, 116, 
473, 3pubB, 0.5200, 3.67, 0.112, 286, 116, CRYSTAL STRUCTURE OF THE BOMBYX MORI LOW MOLECULAR WEIGHT LIPOPROTEIN 7 (BMLP7)
474, 6dwuVA, 0.5199, 3.67, 0.112, 286, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
475, 5bp5A, 0.5198, 3.67, 0.112, 286, 116, CRYSTAL STRUCTURE OF HA17-HA33-IPT
476, 3nbcA, 0.5198, 3.87, 0.121, 163, 116, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 4.4
477, 6dwfH, 0.5197, 3.68, 0.112, 285, 116, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
478, 5bp5B, 0.5197, 3.67, 0.112, 286, 116, CRYSTAL STRUCTURE OF HA17-HA33-IPT
479, 6dwuPB, 0.5196, 3.67, 0.112, 285, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
480, 6dwuJB, 0.5196, 3.79, 0.069, 150, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
481, 5bvpI, 0.5196, 3.34, 0.099, 148, 111, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
482, 4zotA, 0.5196, 3.41, 0.098, 149, 112, CRYSTAL STRUCTURE OF BBKI A DISULFIDE-FREE PLASMA KALLIKREIN INHIBITOR AT 1.4 A RESOLUTION
483, 5ehaA, 0.5194, 3.89, 0.121, 163, 116, CRYSTAL STRUCTURE OF RECOMBINANT MTAL AT 1.35 ANGSTROM RESOLUTION
484, 6dwuR, 0.5193, 3.68, 0.112, 286, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
485, 4x39A, 0.5193, 3.63, 0.078, 239, 115, GALLUS INTERLEUKIN-1 BETA MUTANT - T117A
486, 4lo2B, 0.5192, 3.95, 0.073, 2327, 123, HA17-HA33-LAC
487, 4depD, 0.5192, 3.95, 0.073, 2327, 123, STRUCTURE OF THE IL-1B SIGNALING COMPLEX
488, 4depA, 0.5192, 3.87, 0.121, 163, 116, STRUCTURE OF THE IL-1B SIGNALING COMPLEX
489, 3pubA, 0.5191, 3.65, 0.103, 286, 116, CRYSTAL STRUCTURE OF THE BOMBYX MORI LOW MOLECULAR WEIGHT LIPOPROTEIN 7 (BMLP7)
490, 6dwfG, 0.5188, 3.65, 0.103, 286, 116, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
491, 3nbcB, 0.5188, 3.65, 0.103, 285, 116, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 4.4
492, 6dwfK, 0.5187, 3.68, 0.123, 163, 114, CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT; L55R WITH BOVINE TRYPSIN 
493, 4i0yA, 0.5187, 3.95, 0.120, 163, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT C36R
494, 6dwuTB, 0.5185, 3.74, 0.122, 163, 115, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
495, 4iy8A, 0.5185, 3.77, 0.122, 163, 115, BMLP3 - P21 CRYSTAL FORM
496, 2wryA, 0.5185, 3.77, 0.122, 163, 115, CRYSTAL STRUCTURE OF CHICKEN CYTOKINE INTERLEUKIN 1 BETA
497, 1dzcA, 0.5185, 4.11, 0.156, 3645, 122, HIGH RESOLUTION STRUCTURE OF ACIDIC FIBROBLAST GROWTH FACTOR. MUTANT FGF-4-ALA-(23-154) 24 NMR STRUCTURES
498, 1ilr2, 0.5184, 4.11, 0.156, 3645, 122, CRYSTAL STRUCTURE OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
499, 6dwhG, 0.5183, 3.68, 0.123, 163, 114, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
500, 5fozA, 0.5183, 4.11, 0.156, 3645, 122, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 10
501, 4x38A, 0.5182, 4.11, 0.156, 3645, 122, GALLUS INTERLEUKIN-1 BETA MUTANT - E118A
502, 6dwhI, 0.5176, 3.82, 0.119, 236, 118, CRYSTAL STRUCTURE OF COMPLEX OF BBKI AND BOVINE TRYPSIN 
503, 4xftA, 0.5174, 3.99, 0.119, 163, 118, STRUCTURE OF IL-18 SER MUTANT III
504, 1iltA, 0.5174, 3.68, 0.095, 286, 116, X-RAY STRUCTURE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AT 2.0 ANGSTROMS RESOLUTION
505, 3snvA, 0.5173, 3.31, 0.099, 148, 111, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION  1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
506, 4lo3B, 0.5172, 3.78, 0.122, 163, 115, HA17-HA33-LACNAC
507, 4x37A, 0.5171, 3.69, 0.112, 285, 116, GALLUS INTERLEUKIN-1 MUTANT - E118K
508, 1ybiB, 0.5168, 3.71, 0.123, 163, 114, CRYSTAL STRUCTURE OF HA33A A NEUROTOXIN-ASSOCIATED PROTEIN FROM CLOSTRIDIUM BOTULINUM TYPE A
509, 4qd2C, 0.5166, 3.60, 0.115, 163, 113, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
510, 3snvB, 0.5166, 3.66, 0.070, 149, 114, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION  1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
511, 6dwuHB, 0.5165, 3.87, 0.121, 163, 116, struct.pdbx_descriptor               Cationic trypsin (E.C.3.4.21.4); Kunitz-type inihibitor  
512, 4iy8D, 0.5165, 3.68, 0.097, 153, 113, BMLP3 - P21 CRYSTAL FORM
513, 5foyA, 0.5164, 3.98, 0.137, 163, 117, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 7
514, 4r6uB, 0.5164, 3.83, 0.121, 163, 116, IL-18 RECEPTOR COMPLEX
515, 4xftB, 0.5163, 3.72, 0.122, 163, 115, STRUCTURE OF IL-18 SER MUTANT III
516, 4iy9A, 0.5163, 4.04, 0.102, 154, 118, BMLP3 - C2 CRYSTAL FORM
517, 4jpzE, 0.5161, 3.68, 0.112, 286, 116, VOLTAGE-GATED SODIUM CHANNEL 1.2 C-TERMINAL DOMAIN IN COMPLEX WITH FGF13U AND CA2+/CALMODULIN
518, 4iy8C, 0.5160, 3.59, 0.071, 152, 113, BMLP3 - P21 CRYSTAL FORM
519, 1hibA, 0.5160, 3.45, 0.072, 151, 111, THE STRUCTURE OF AN INTERLEUKIN-1 BETA MUTANT WITH REDUCED BIOACTIVITY SHOWS MULTIPLE SUBTLE CHANGES IN CONFORMATION THAT AFFECT PROTEIN- PROTEIN RECOGNITION
520, 3pg0A, 0.5159, 3.74, 0.120, 235, 117, CRYSTAL STRUCTURE OF DESIGNED 3-FOLD SYMMETRIC PROTEIN THREEFOIL
521, 8i1bA, 0.5156, 3.79, 0.122, 163, 115, A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B
522, 4qd2I, 0.5156, 3.38, 0.089, 148, 112, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
523, 5g37A, 0.5153, 3.79, 0.122, 163, 115, MR STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 5
524, 1ybiA, 0.5153, 4.22, 0.121, 473, 124, CRYSTAL STRUCTURE OF HA33A A NEUROTOXIN-ASSOCIATED PROTEIN FROM CLOSTRIDIUM BOTULINUM TYPE A
525, 1jlyA, 0.5153, 3.69, 0.123, 163, 114, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
526, 3nbdA, 0.5152, 3.66, 0.078, 239, 115, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 7.1
527, 2ermA, 0.5152, 4.07, 0.093, 154, 118, SOLUTION STRUCTURE OF A BIOLOGICALLY ACTIVE HUMAN FGF-1 MONOMER COMPLEXED TO A HEXASACCHARIDE HEPARIN-ANALOGUE
528, 1jlxA, 0.5152, 3.19, 0.064, 131, 109, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
529, 4iy9B, 0.5151, 3.77, 0.070, 144, 115, BMLP3 - C2 CRYSTAL FORM
530, 1jlyB, 0.5151, 3.68, 0.123, 163, 114, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
531, 5l1dE, 0.5144, 3.64, 0.034, 364, 118, 
532, 4efrD, 0.5144, 3.95, 0.103, 149, 117, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
533, 4xfuA, 0.5143, 3.68, 0.123, 163, 114, STRUCTURE OF IL-18 SER MUTANT V
534, 1jlxB, 0.5143, 3.58, 0.098, 154, 112, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
535, 31biA, 0.5142, 3.70, 0.079, 143, 114, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY SER) (C71S)
536, 5muaB, 0.5140, 3.18, 0.092, 125, 109, PSL1A-E64 COMPLEX
537, 1iraX, 0.5137, 3.70, 0.112, 285, 116, COMPLEX OF THE INTERLEUKIN-1 RECEPTOR WITH THE INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL1RA)
538, 1iltB, 0.5137, 4.01, 0.110, 159, 118, X-RAY STRUCTURE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AT 2.0 ANGSTROMS RESOLUTION
539, 1bldA, 0.5137, 3.57, 0.061, 284, 114, BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER NMR
540, 5muaA, 0.5133, 3.80, 0.095, 286, 116, PSL1A-E64 COMPLEX
541, 4eeeB, 0.5133, 3.24, 0.083, 124, 109, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
542, 4efpB, 0.5132, 3.80, 0.122, 163, 115, BOMBYX MORI LIPOPROTEIN 7 ISOLATED FROM ITS NATURAL SOURCE AT 1.33 A RESOLUTION
543, 4jpzA, 0.5130, 3.70, 0.121, 239, 116, VOLTAGE-GATED SODIUM CHANNEL 1.2 C-TERMINAL DOMAIN IN COMPLEX WITH FGF13U AND CA2+/CALMODULIN
544, 4efrB, 0.5129, 3.61, 0.034, 367, 117, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
545, 1bffA, 0.5129, 3.71, 0.096, 155, 115, THE 154 AMINO ACID FORM OF HUMAN BASIC FIBROBLAST GROWTH FACTOR
546, 4qd2H, 0.5127, 3.67, 0.105, 154, 114, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
547, 4efrA, 0.5127, 3.77, 0.128, 235, 117, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
548, 4p0kA, 0.5125, 3.50, 0.089, 148, 112, CRYSTAL STRUCTURE OF DOUBLE LOOP-SWAPPED INTERLEUKIN-36RA
549, 5uc6A, 0.5124, 3.70, 0.121, 239, 116, STRUCTURAL INSIGHTS INTO IL-1 ALPHA RECOGNITION BY A NAPHTHYL-MODIFIED APTAMER THAT MIMICS IL-1RI DOMAIN III
550, 4efqB, 0.5124, 3.58, 0.071, 150, 113, BOMBYX MORI LIPOPROTEIN 7 - PLATINUM DERIVATIVE AT 1.94 A RESOLUTION
551, 4izeA, 0.5123, 3.26, 0.090, 140, 111, CRYSTAL STRUCTURE OF IL-36GAMMA
552, 5hn1A, 0.5122, 3.49, 0.099, 146, 111, CRYSTAL STRUCTURE OF INTERLEUKIN-37
553, 1ilr1, 0.5121, 3.71, 0.112, 286, 116, CRYSTAL STRUCTURE OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
554, 6ncuB, 0.5120, 3.70, 0.034, 364, 118, INTERLEUKIN-37 RESIDUES 53-206- DIMER 
555, 4xfuB, 0.5120, 3.69, 0.113, 284, 115, STRUCTURE OF IL-18 SER MUTANT V
556, 4efrC, 0.5120, 3.97, 0.043, 299, 117, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
557, 1l2hA, 0.5119, 3.37, 0.089, 148, 112, CRYSTAL STRUCTURE OF INTERLEUKIN 1-BETA F42W/W120F MUTANT
558, 5xg5A, 0.5117, 3.25, 0.082, 133, 110, CRYSTAL STRUCTURE OF MITSUBA-1 WITH BOUND NACGAL
559, 4efpA, 0.5117, 3.97, 0.043, 299, 117, BOMBYX MORI LIPOPROTEIN 7 ISOLATED FROM ITS NATURAL SOURCE AT 1.33 A RESOLUTION
560, 3hbwA, 0.5117, 3.78, 0.128, 235, 117, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR 2A (FHF2A) ALSO REFERRED TO AS FIBROBLAST GROWTH FACTOR 13A (FGF13A)
561, 3hbwB, 0.5116, 3.98, 0.034, 299, 117, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR 2A (FHF2A) ALSO REFERRED TO AS FIBROBLAST GROWTH FACTOR 13A (FGF13A)
562, 3p6iA, 0.5115, 4.29, 0.074, 3570, 122, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION  2: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
563, 1blaA, 0.5114, 3.71, 0.121, 233, 116, BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER NMR
564, 5y9vA, 0.5113, 3.65, 0.106, 149, 113, CRYSTAL STURCTURE OF DIAMONDBACK MOTH RYANODINE RECEPTOR N-TERMINAL DOMAIN
565, 4zktA, 0.5110, 4.00, 0.034, 299, 117, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
566, 4x3aA, 0.5109, 3.80, 0.078, 149, 116, GALLUS INTERLEUKIN-1 BETA MUTANT - R140A
567, 3nj5A, 0.5109, 3.33, 0.055, 275, 110, CRYSTAL STRUCTURE OF CHICKEN IL-1 HYDROPHOBIC CAVITY MUTANT 157
568, 4p0lA, 0.5108, 3.43, 0.090, 145, 111, CRYSTAL STRUCTURE OF DOUBLE LOOP-SWAPPED INTERLEUKIN-36RA WITH ADDITIONAL POINT MUTATIONS
569, 4zktE, 0.5107, 3.76, 0.088, 143, 114, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
570, 4i96A, 0.5103, 2.99, 0.140, 155, 107, CRYSTAL STRUCTURE OF THE N-TERMINAL TWO DOMAINS OF THE SKELETAL MUSCLE RYANODINE RECEPTOR (RABBIT RYR1) RESIDUES 217-536
571, 4zktC, 0.5102, 3.30, 0.036, 269, 110, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
572, 1md6A, 0.5101, 3.68, 0.117, 147, 111, HIGH RESOLUTION CRYSTAL STRUCTURE OF MURINE IL-1F5 REVEALS UNIQUE LOOP CONFORMATION FOR SPECIFICITY
573, 4efqA, 0.5100, 3.75, 0.121, 234, 116, BOMBYX MORI LIPOPROTEIN 7 - PLATINUM DERIVATIVE AT 1.94 A RESOLUTION
574, 1q1uA, 0.5099, 3.53, 0.107, 148, 112, CRYSTAL STRUCTURE OF HUMAN FHF1B (FGF12B)
575, 1qqlA, 0.5097, 3.75, 0.121, 233, 116, THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7/1 CHIMERA
576, 2j3pA, 0.5094, 3.10, 0.157, 129, 108, CRYSTAL STRUCTURE OF RAT FGF1 AT 1.4 A
577, 3ud9A, 0.5091, 3.80, 0.112, 286, 116, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
578, 1g82D, 0.5091, 3.77, 0.121, 234, 116, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
579, 3f62B, 0.5090, 3.82, 0.095, 144, 116, CRYSTAL STRUCTURE OF HUMAN IL-18 IN COMPLEX WITH ECTROMELIA VIRUS IL- 18 BINDING PROTEIN
580, 4ionB, 0.5088, 3.47, 0.064, 151, 109, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL)
581, 5l1dA, 0.5085, 3.76, 0.121, 234, 116, 
582, 4dckC, 0.5085, 3.84, 0.095, 151, 116, CRYSTAL STRUCTURE OF THE C-TERMINUS OF VOLTAGE-GATED SODIUM CHANNEL IN COMPLEX WITH FGF13 AND CAM
583, 5w59A, 0.5084, 3.80, 0.104, 157, 115, CRYSTAL STRUCTURE OF A MONOMERIC HUMAN FGF9 IN COMPLEX WITH THE ECTODOMAIN OF HUMAN FGFR1C
584, 4p0jA, 0.5078, 3.66, 0.097, 145, 113, CRYSTAL STRUCTURE OF LOOP-SWAPPED INTERLEUKIN-36RA
585, 1w3gA, 0.5078, 3.84, 0.096, 154, 115, HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH TWO N-ACETYLLACTOSAMINE MOLECULES.
586, 4iybB, 0.5077, 3.81, 0.096, 150, 114, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH GALACTOSE
587, 3f1rA, 0.5077, 3.79, 0.121, 235, 116, CRYSTAL STRUCTURE OF FGF20 DIMER
588, 5l1dG, 0.5076, 3.61, 0.090, 144, 111, 
589, 3ud8A, 0.5076, 3.26, 0.064, 145, 110, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
590, 3f1rB, 0.5075, 3.78, 0.121, 234, 116, CRYSTAL STRUCTURE OF FGF20 DIMER
591, 3winB, 0.5072, 3.43, 0.090, 149, 111, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
592, 4qd2D, 0.5071, 3.43, 0.090, 149, 111, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
593, 1g82C, 0.5071, 3.21, 0.074, 127, 108, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
594, 4j23B, 0.5066, 3.08, 0.148, 155, 108, LOW RESOLUTION CRYSTAL STRUCTURE OF THE FGFR2D2D3/FGF1/SR128545 COMPLEX
595, 2j3pB, 0.5066, 3.88, 0.060, 177, 117, CRYSTAL STRUCTURE OF RAT FGF1 AT 1.4 A
596, 4j2sA, 0.5065, 3.68, 0.060, 1235, 116, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH DI- LACNAC
597, 4izxA, 0.5065, 3.96, 0.104, 147, 115, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH LACTOSE
598, 6ncuA, 0.5063, 3.92, 0.096, 152, 115, INTERLEUKIN-37 RESIDUES 53-206- DIMER 
599, 3ud7B, 0.5061, 3.78, 0.095, 143, 116, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
600, 3im5B, 0.5060, 3.69, 0.060, 1235, 116, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (RESIDUES 1-217)
601, 5y9vB, 0.5059, 3.45, 0.145, 259, 110, CRYSTAL STURCTURE OF DIAMONDBACK MOTH RYANODINE RECEPTOR N-TERMINAL DOMAIN
602, 1w3fA, 0.5059, 3.70, 0.060, 1235, 116, CRYSTAL STRUCTURE OF THE HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH N-ACETYLLACTOSAMINE IN THE GAMMA MOTIF
603, 1ihkA, 0.5057, 4.08, 0.120, 154, 117, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 9 (FGF9)
604, 4p0jB, 0.5056, 3.80, 0.121, 234, 116, CRYSTAL STRUCTURE OF LOOP-SWAPPED INTERLEUKIN-36RA
605, 1nunA, 0.5056, 3.37, 0.083, 138, 109, CRYSTAL STRUCTURE ANALYSIS OF THE FGF10-FGFR2B COMPLEX
606, 1w3aA, 0.5055, 3.22, 0.073, 131, 109, THREE DIMENSIONAL STRUCTURE OF A NOVEL PORE-FORMING LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS
607, 3n0kA, 0.5054, 3.24, 0.073, 134, 109, PROTEINASE INHIBITOR FROM COPRINOPSIS CINEREA
608, 3k1xD, 0.5053, 3.09, 0.103, 128, 107, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
609, 3ilaF, 0.5053, 3.54, 0.063, 155, 111, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
610, 1g82B, 0.5049, 3.60, 0.110, 145, 109, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
611, 3udaB, 0.5048, 3.18, 0.056, 140, 107, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
612, 2y9xG, 0.5047, 4.41, 0.065, 3570, 124, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
613, 4q9pA, 0.5045, 3.46, 0.108, 148, 111, CRYSTAL STRUCTURE OF C16T/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
614, 4iybA, 0.5044, 3.63, 0.090, 146, 111, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH GALACTOSE
615, 3k1xC, 0.5044, 3.78, 0.080, 147, 113, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
616, 1g82A, 0.5044, 4.16, 0.134, 312, 119, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
617, 2irtA, 0.5042, 3.18, 0.056, 140, 107, INITIAL CRYSTALLOGRAPHIC ANALYSES OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
618, 1n4kA, 0.5042, 3.58, 0.081, 157, 111, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR BINDING CORE IN COMPLEX WITH IP3
619, 2y9xH, 0.5039, 4.39, 0.065, 3570, 124, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
620, 4keiA, 0.5038, 3.13, 0.112, 129, 107, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (1-217) DISEASE MUTANT P164S
621, 3jutD, 0.5038, 3.58, 0.081, 157, 111, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
622, 1k5uC, 0.5037, 3.64, 0.106, 286, 113, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
623, 4ow4A, 0.5036, 3.84, 0.095, 286, 116, BETA-TREFOIL DESIGNED BY FOLDING NUCLEUS SYMMETRIC EXPANSION (PHIFOIL)
624, 4ionA, 0.5036, 3.58, 0.090, 155, 111, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL)
625, 3jutC, 0.5036, 3.29, 0.093, 134, 108, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
626, 2y9wD, 0.5035, 3.28, 0.101, 132, 109, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT
627, 2y9wC, 0.5035, 3.20, 0.065, 139, 107, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT
628, 3jutA, 0.5034, 3.20, 0.065, 139, 107, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
629, 2y9xF, 0.5034, 3.90, 0.096, 150, 114, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
630, 4jq0A, 0.5033, 3.11, 0.093, 127, 107, VOLTAGE-GATED SODIUM CHANNEL 1.5 C-TERMINAL DOMAIN IN COMPLEX WITH FGF12B AND CA2+/CALMODULIN
631, 3k1xB, 0.5032, 3.75, 0.061, 175, 114, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
632, 4cjmA, 0.5031, 3.94, 0.052, 170, 116, CRYSTAL STRUCTURE OF HUMAN FGF18
633, 1k5uB, 0.5031, 4.17, 0.134, 312, 119, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
634, 4gaiB, 0.5030, 3.61, 0.090, 157, 111, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA
635, 3b9uA, 0.5030, 3.75, 0.088, 147, 114, CRYSTAL STRUCTURE OF L26N/D28N/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
636, 2y9xE, 0.5026, 3.37, 0.093, 139, 108, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
637, 4g9nB, 0.5025, 4.19, 0.126, 312, 119, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ IN COMPLEX WITH N -ACETYL-GALACTOSAMINE
638, 2irtB, 0.5024, 3.45, 0.036, 150, 110, INITIAL CRYSTALLOGRAPHIC ANALYSES OF A RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
639, 5hn1B, 0.5020, 3.11, 0.121, 130, 107, CRYSTAL STRUCTURE OF INTERLEUKIN-37
640, 4kekA, 0.5019, 3.86, 0.026, 162, 114, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (1-217) DISEASE MUTANT R176Q
641, 4f34A, 0.5019, 3.58, 0.063, 157, 111, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
642, 3k1xA, 0.5018, 3.08, 0.113, 127, 106, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
643, 3badA, 0.5018, 3.43, 0.083, 136, 108, CRYSTAL STRUCTURE OF D70A/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
644, 2afgB, 0.5015, 3.19, 0.093, 131, 107, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
645, 4g9mB, 0.5014, 3.23, 0.065, 140, 107, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ
646, 4cjmB, 0.5013, 3.18, 0.120, 130, 108, CRYSTAL STRUCTURE OF HUMAN FGF18
647, 3llpA, 0.5013, 3.65, 0.089, 157, 112, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
648, 1ev2D, 0.5013, 3.99, 0.086, 145, 116, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
649, 1fq9A, 0.5011, 3.51, 0.090, 292, 111, CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
650, 6i0zB, 0.5010, 3.39, 0.093, 136, 108, CRYSTAL STRUCTURE OF FASCIN IN COMPLEX WITH COMPOUND 1 
651, 3badB, 0.5010, 3.88, 0.053, 173, 114, CRYSTAL STRUCTURE OF D70A/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
652, 1hknD, 0.5010, 3.22, 0.120, 130, 108, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
653, 3ilaG, 0.5009, 3.29, 0.102, 129, 108, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 N-TERMINAL DOMAIN (9- 205)
654, 1cvsB, 0.5009, 2.96, 0.058, 123, 103, CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX
655, 3jutB, 0.5008, 3.23, 0.065, 140, 107, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
656, 1fq9B, 0.5008, 3.22, 0.111, 130, 108, CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
657, 1cvsA, 0.5008, 3.40, 0.093, 135, 108, CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX
658, 2afgA, 0.5006, 3.39, 0.093, 136, 108, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
659, 5mvzU, 0.5005, 3.26, 0.102, 130, 108, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
660, 1ijtA, 0.5005, 3.44, 0.083, 136, 108, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 4 (FGF4)
661, 2ilaA, 0.5004, 3.61, 0.071, 141, 112, STRUCTURE OF INTERLEUKIN 1ALPHA AT 2.7-ANGSTROMS RESOLUTION
662, 3q7yA, 0.5002, 3.24, 0.093, 130, 108, CRYSTAL STRUCTURE OF K15R/E18D/Y22W/H41G/F44W/E51D/E53P/K57R/E60D/Y64W/H82G/F85W/E90D/E94P /K98R/E101D/Y108W/H129G/F132W/E137D SYMFOIL-4P: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
663, 4ow4B, 0.5001, 3.23, 0.084, 129, 107, BETA-TREFOIL DESIGNED BY FOLDING NUCLEUS SYMMETRIC EXPANSION (PHIFOIL)
664, 4eeeD, 0.5001, 3.28, 0.102, 128, 108, CRYSTAL STRUCTURE OF YLDV 14L IL-18 BINDING PROTEIN IN COMPLEX WITH HUMAN IL-18
665, 3ud7C, 0.5001, 3.56, 0.056, 140, 108, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
666, 1e0oC, 0.5001, 3.33, 0.083, 132, 108, CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX
